DexCom, Inc. (DXCM)
Upgrades & Downgrades
Latest DXCM news
Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favor...
26 September 2023
Outside of a handful of highflying technology stocks, U.S. stocks have been practically flat in 2023, but on Wall Street, some analysts remain as bullish as ever.
3 Healthcare Stocks That Should Be on Every Investor's Radar This Fall
23 September 2023
As of September 19, S&P 500 healthcare stocks were down 3.2% for the year. Of the 11 sectors, its year to date (YTD) performance is the second worst only behind utilities.
2 Healthcare Stocks That Could Make You Richer
22 September 2023
Vertex has almost no weak spots thanks to a solid core franchise and several promising programs. DexCom is helping improve the lives of diabetes patients, and the company still has lots of room to gro...
3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought
21 September 2023
A remarkable 30-year bull run for the Nasdaq 100 saw it gain nearly 4,000% by 2020. But, the party came to a screeching halt when the pandemic hit.
DexCom (DXCM) Launches Latest CGM Sensor ONE in France
18 September 2023
DexCom's (DXCM) latest CGM sensor, DexCom ONE, secures reimbursement coverage in France, bringing the real-time CGM sensor to half a million diabetes patients in the country.
Will DexCom Stock Recover To Its Pre-Inflation Shock Highs Of $160?
18 September 2023
The notable increase in DexCom's revenues over recent quarters has also contributed to the stock recovery.
Why DexCom Stock Dove by 5% Today
15 September 2023
A Raymond James analyst cut his price target on the specialty medical device maker. It was the second such price target cut so far this month.
Here's Why You Should Retain DexCom (DXCM) Stock for Now
14 September 2023
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
DexCom (DXCM) Rises 7% in One Week: What's Driving It?
12 September 2023
DexCom's (DXCM) shares have rallied nearly 7% over the past week, presumably on positive outlook for its CGM devices amid rising competition.